apl. Prof. Dr. Lucie Heinzerling



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Expression of Senescence Markers - Is Predictive for Immune Therapy with Checkpoint Inhibitors? (2018) Moreira A, Gross S, Kirchberger MC, Erdmann M, Schuler G, Heinzerling L Conference contribution FV03 MEK Inhibitors improved the Survival of NRAS-mutated Melanoma Patients by using Checkpoint Inhibitors: Results of a retrospective, multicenter Analysis of 364 Patients (2018) Kirchberger MC, Ugurel S, Mangana J, Heppt M, Eigentler T, Berking C, Schadendorf D, et al. Conference contribution Fear of cancer progression in patients with stage IA malignant melanoma (2018) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Journal article Can checkpoint inhibitor therapy improve response to chemotherapy? (2018) Kirchberger MC, Schilling B, Haferkamp S, Boßerhoff AK, Schuler G, Heinzerling L Journal article Managing toxicities of immunotherapies - a side effect register for rare and severe side effects of checkpoint Inhibitor therapy (2018) Heinzerling L, Schuler G Conference contribution Effective anti-programmed death-1 therapy in a SUFU-mutated patient with Gorlin-Goltz syndrome (2018) Moreira A, Kirchberger MC, Toussaint F, Erdmann M, Schuler G, Heinzerling L Journal article Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients (2018) Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, et al. Journal article Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients (2018) Kirchberger MC, Moreira A, Erdmann M, Schuler G, Heinzerling L Journal article BRAF Inhibitors and Radiation Do Not Act Synergistically to Inhibit WT and V600E BRAF Human Melanoma (2018) Walter L, Heinzerling L Journal article, Original article Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports (2018) Schliep S, Agaimy A, Kiesewetter F, Schuler G, Heinzerling L, Cavallaro AJ Journal article